XOSPATA Is a Targeted Therapy
XOSPATA works differently than traditional chemotherapy. Traditional chemotherapy works by killing fast-growing cells, which can include cancer cells and other types of cells. Targeted therapies are designed to target certain features of cancer cells, like mutations. Other cells in the body may still be affected during treatment, but this type of therapy is designed with a specific target in mind.
When you have FLT3m+ AML, the number of leukemia cells increases in the bone marrow, leaving less room for healthy cells to grow. XOSPATA targets the FLT3 mutation, which may keep AML cells from growing in the bone marrow. With fewer leukemia cells, the bone marrow may have more room for healthy blood cells.